| Medgenics Adds Two Key Opinion Leaders to Strategic Advisory Board - MarketWatch (press release) |
|
|
MarketWatch (press release) Renowned for his studies on end-stage renal disease and renal anemia, Dr. Fishbane is on the Editorial Board for the Journal of the American Society of Nephrology and Advances in Renal Replacement and is a reviewer for several journals, including the |